Eradication of chronic Helicobacter pylori infection by therapeutic vaccination
Open Access
- 1 July 1998
- Vol. 43 (1), 7-8
- https://doi.org/10.1136/gut.43.1.7
Abstract
The development of a vaccine against H pylori which confers long term protective immunity is the best strategy to circumvent the problem of antibiotic resistance and to eradicate H pylori on a global scale. The feasibility of inducing protective immune responses to helicobacter by oral vaccination with bacterial antigens and a mucosal adjuvant was initially demonstrated in the H felis murine model.4-6 Vaccination with both H pylori urease5 and heat shock proteins (HspA and HspB)6 protected against subsequent challenge withH felis. However, H felis lacks many of the virulence factors present inH pylori, such as thecag pathogenicity island7 and the cytotoxin VacA,8 precluding analysis of these antigens as candidate vaccines in the H felis model. The development of mouse adapted H pyloristrains which cause chronic infection in mice was a major advance.9 The H pylori mouse model has permitted the testing of vaccines containing purifiedH pylori antigens against homologous challenge infection.9 To date, a number of protectiveH pylori antigens have been identified which confer immunity against H pylori infection in the mouse, including purified VacA,9urease,9 CagA,10 and catalase.11Keywords
This publication has 21 references indexed in Scilit:
- Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantVaccine, 1998
- Resistance of Helicobacter pylori to antibioticsAlimentary Pharmacology & Therapeutics, 1997
- The adjuvant effect of a non‐toxic mutant of heat‐labile enterotoxin of Escherichia coli for the induction of measles virus‐specific CTL responses after intranasal co‐immunization with a synthetic peptideImmunology, 1996
- Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in miceGastroenterology, 1995
- Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.Gut, 1995
- A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.The Journal of Experimental Medicine, 1994
- Short-term low-dose triple therapy for the eradication of Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 1994
- Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.The Journal of Experimental Medicine, 1994
- Therapeutic Immunisation against hellcobacter InfectionThe Lancet, 1994
- Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis modelThe Lancet, 1992